All News | RheumNow

All News

Resistant Hypertension Common in SLE

Save

d RheumNow

Mar 21, 2019

Rates of resistant hypertension were doubled among patients with systemic lupus erythematosus (SLE), significantly increasing their mortality risks, a retrospective single-center study found.

Read Article

renal.genes_.jpg

Improved Mortality Trends in Lupus Nephritis

Save

d Jack Cush, MD

Mar 20, 2019

The mortality rate from end- stage renal disease (ESRD) in lupus nephritis (LN) patients has significantly decreased in the last decade.

Read Article

Risky Painkillers Commonly Prescribed for Osteoarthritis

Save

d RheumNow

Mar 20, 2019

Published guidelines warn that treating osteoarthritis (OA) with opioids and benzodiazepines can boost patients' risk of falling.

Read Article

Cyclosporin and IVIG Effective in Kawasaki's Disease

Save

d Jack Cush, MD

Mar 19, 2019

A Lancet study has shown that adding cyclosporin to intravenous immunoglobulin (IVIG) Kawasaki disease patients, who were predicted to be resistant to IVIG, was both safe and effective in averting severe coronary artery outcomes.

Read Article

serum soluble programmed cell death protein 1 (sPD-1)shown to correlate w/ BVAS activity in 59 pts w/ ANCA-associated vasculitis (AAV). sPD-1 was correlated with hemoglobin and serum albumin, but not ESR or CRP. https://t.co/GOShh8Kwb2

Links:

https://buff.ly/2Fl9L6z

Dr. John Cush RheumNow ( View Tweet)

Mar 22, 2019

Prevalence of gout continues to rise. NHANES data say prevalence of gout is 9.2 million inUS adults (2015-2016) (5.9 mill men; 3.3 mil women); hyperuricemia prevalences is 20.0%. ULT use in gout was 33% between 2007-2014. https://t.co/nDEJM7gTGA

Links:

https://buff.ly/2TiT1Sx

Dr. John Cush RheumNow ( View Tweet)

Mar 22, 2019

A review of OP Guidelines, published in Osteoporosis International, shows only 27 of the 70 guidelines patient Beliefs, Values or Perceptions. https://t.co/zGoX2aaxdP

Links:

https://buff.ly/2Y9Na5K

Dr. John Cush RheumNow ( View Tweet)

Mar 21, 2019

AAOS meeting presentation of 114,698 TKR pts shows younger pts (age <40) have a 3 fold greater risk of early mechanical complications & are 63% more likely to be rehospitalized w/in 90D. Younger have more obesity, DM, inflamm arthritis, ACL surgery https://t.co/DoePD5GXl9

Links:

https://buff.ly/2uiwafH

Dr. John Cush RheumNow ( View Tweet)

Mar 21, 2019

The risk of acute coronary syndromes in inflammatory myositis patients is doubled, especially in the first year (vs general population) and in older individuals. (HR 2.4; 1.8-3.2) - 7% IIM vs 3.3% in controls at 5 yrs. https://t.co/lCWGfm81EN

Links:

https://buff.ly/2W8ahM0

Dr. John Cush RheumNow ( View Tweet)

Mar 21, 2019

QD Clinic - Goldilocks and Osteoarthritis | RheumNow - Finding the Right Ddose for the Right Patient? https://t.co/SMmVYDxPeX

Links:

https://buff.ly/2WeUCe6

Dr. John Cush RheumNow ( View Tweet)

Mar 20, 2019

FREE Online viewing of RheumNow Live - Friday 3/22 at 1pm EST. 2 hr discussion blocks on RA, PsA, AS, SLE, Vasculitis. 10 "TED" talks interspersed from Cush, Calabrese, Van Vollenhoven, Schett, Matteson, Wolfe, Oransky,etc. SEE YOU THERE OR REGISTER HERE https://t.co/lbrJ0Dp1Hb

Links:

https://buff.ly/2VWr8RW

Dr. John Cush RheumNow ( View Tweet)

Mar 20, 2019

Rheumatologists are the happiest specialists! https://t.co/C6aaHWq7qf @ACRheum Choose Rheumatology and Be Happy! @alhkim

Links:

Happiness in Rheumatology - The Rheumatologist

Jeff Sparks jeffsparks ( View Tweet)

Mar 20, 2019

Study of 151,305 pts from Clinical Practice Research Datalink, shows that THR/TKR patients exposed to statins for 1-5 years had ~25% reduced risk of arthroplasty revision (HR 0.74 (0.62, 0.88)). https://t.co/AQhKHuAwkD

Links:

https://buff.ly/2ThWoJx

Dr. John Cush RheumNow ( View Tweet)

Mar 20, 2019

Pain signaling via NMDA receptors in the brain can be treated with drugs that block NMDA receptors (ketamine, methadone, memantine, amantadine, dextromethorphan). Metanalysis of memantine (15 studies) shows little benefit. https://t.co/72yfYzDXhV

Links:

https://buff.ly/2W9KuTK

Dr. John Cush RheumNow ( View Tweet)

Mar 20, 2019

Brain fog (Fibro Fog) is common with sleep disorders and fibromyalgia. Manifests as memory problems, poor mental focus, forgetfulness - all correctable with sleep medicine evaluation and sleep assistance. https://t.co/e6CXXkYV39

Links:

https://buff.ly/2D3UE3J

Dr. John Cush RheumNow ( View Tweet)

Mar 19, 2019

Study of 21,016 SLE patients from Korean Health Claims databases shows SLE patients have a higher risk of cancer than controls (OR 1.44; 95% CI 1.33–1.56) with highre rates of cervical, thyroid, ovarian, oral cancer, lymphoma, leukemia, & multiple myeloma https://t.co/NKR9i4ccfU

Links:

https://buff.ly/2W8DxT4

Dr. John Cush RheumNow ( View Tweet)

Mar 19, 2019

Time to register for this weeks RheumNow Live. Free online streaming video - 16 hrs of Innovative lectures and Q&A Panels from friday afternoon 3/22, till noon Sunday 3/24. Register for FREE at https://t.co/wIgS5rq4UE

Links:

https://buff.ly/2VRUAbQ

Dr. John Cush RheumNow ( View Tweet)

Mar 19, 2019

QD Clinic - When To Stop MTX- Should/Can a Patient ever stop MTX? | RheumNow https://t.co/z0Dhwdbr3Q

Links:

https://buff.ly/2Wczsx7

Dr. John Cush RheumNow ( View Tweet)

Mar 18, 2019

European Commission Approves MabThera (rituximab) for use in Pemphigus, US FDA approved it in 6/18; RTX is now approved in 4 autoimmune disorders in the US & Europe (RA, GPA, MPA, Pemphigus) - Not approved for use in children https://t.co/dJJfPdXuWQ(rituxim/364143/index.html

Links:

https://buff.ly/2Td0bYj

Dr. John Cush RheumNow ( View Tweet)

Mar 18, 2019

Nice comprehensive full read review of the Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline from the JBMR. https://t.co/Eh9xfPJ2B0

Links:

https://buff.ly/2Y4Rovp

Dr. John Cush RheumNow ( View Tweet)

Mar 18, 2019

×